2.84 USD
-0.09 (-3.07%)
2.8407 USD
+0 (+0.02%)
GNPX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. GNPX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GNPX does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- GNPX had negative earnings in the past year.
- GNPX had a negative operating cash flow in the past year.
- In the past 5 years GNPX always reported negative net income.
- In the past 5 years GNPX always reported negative operating cash flow.
1.2 Ratios
- GNPX has a worse Return On Assets (-518.59%) than 94.29% of its industry peers.
- Looking at the Return On Equity, with a value of -1320.11%, GNPX is doing worse than 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -518.59% | ||
| ROE | -1320.11% | ||
| ROIC | N/A |
ROA(3y)-300.81%
ROA(5y)-201.57%
ROE(3y)-614.27%
ROE(5y)-390.18%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for GNPX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The number of shares outstanding for GNPX has been increased compared to 1 year ago.
- The number of shares outstanding for GNPX has been increased compared to 5 years ago.
- There is no outstanding debt for GNPX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- Based on the Altman-Z score of -68.07, we must say that GNPX is in the distress zone and has some risk of bankruptcy.
- GNPX's Altman-Z score of -68.07 is on the low side compared to the rest of the industry. GNPX is outperformed by 92.00% of its industry peers.
- There is no outstanding debt for GNPX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -68.07 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- GNPX has a Current Ratio of 0.83. This is a bad value and indicates that GNPX is not financially healthy enough and could expect problems in meeting its short term obligations.
- GNPX's Current ratio of 0.83 is on the low side compared to the rest of the industry. GNPX is outperformed by 87.24% of its industry peers.
- A Quick Ratio of 0.83 indicates that GNPX may have some problems paying its short term obligations.
- GNPX has a worse Quick ratio (0.83) than 86.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.83 | ||
| Quick Ratio | 0.83 |
3. Growth
3.1 Past
- GNPX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 70.08%, which is quite impressive.
EPS 1Y (TTM)70.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.95%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- The Earnings Per Share is expected to grow by 41.33% on average over the next years. This is a very strong growth
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y99.72%
EPS Next 2Y41.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- GNPX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year GNPX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- GNPX's earnings are expected to grow with 41.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.33%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- GNPX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
GENPREX INC / GNPX FAQ
What is the ChartMill fundamental rating of GENPREX INC (GNPX) stock?
ChartMill assigns a fundamental rating of 2 / 10 to GNPX.
Can you provide the valuation status for GENPREX INC?
ChartMill assigns a valuation rating of 1 / 10 to GENPREX INC (GNPX). This can be considered as Overvalued.
What is the profitability of GNPX stock?
GENPREX INC (GNPX) has a profitability rating of 0 / 10.
What is the expected EPS growth for GENPREX INC (GNPX) stock?
The Earnings per Share (EPS) of GENPREX INC (GNPX) is expected to grow by 99.72% in the next year.